BC
ITCI

Brookfield Corp’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Brookfield Corp’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-29,323
Closed -$1.86M – 550
2023
Q2 		$1.86M Sell
29,323
-64,824
-69% -$4.04M 0.01% 414
2023
Q1 		$5.1M Buy
94,147
+64,202
+214% +$3.1M 0.02% 286
2022
Q4 		$1.58M Sell
29,945
-18,817
-39% -$943K 0.01% 443
2022
Q3 		$2.27M Buy
+48,762
New +$2.55M 0.01% 434
2022
Q2 		– Sell
-25,540
Closed -$1.56M – 773
2022
Q1 		$1.56M Buy
+25,540
New +$1.33M 0.01% 431

Other funds holding ITCI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return